Barely Significant
← all excerpts

Interactome of Aiolos/Ikaros Reveals Combination Rationale of Cereblon Modulators with HDAC Inhibitors in DLBCL.

Clin Cancer Res · 2022 · PMC9662945 · PMID 35583604

1
hedged sentence
closest p
boldest claim

The sentences

a slight trendno p-value reported
Through quantification of these foci, we establish that Aiolos and Ikaros each are in complex with HDAC1 and HDAC2 with a slight trend towards greater interaction between Aiolos and HDAC1/2 compared with Ikaros ( Fig. 4B ; Supplementary Fig.

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.